Clinical Trial Update: Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a combination of docetaxel, cisplatin, 5-fluorouracil, and leucovorin in squamous cell carcinoma of the head and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Leucovorin (folinic acid)
• Taxotere (docetaxel)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Squamous Cell Carcinoma, Carcinoma of Head and/or Neck | Phase 1, Phase 2 | Status: COMPLETED